Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-089126
Filing Date
2025-09-10
Accepted
2025-09-10 17:26:30
Documents
20

Document Format Files

Seq Description Document Type Size
1 S-3 capr-20250910xs3.htm S-3 635159
2 EX-1.2 capr-20250910xex1d2.htm EX-1.2 298609
3 EX-5.1 capr-20250910xex5d1.htm EX-5.1 48577
4 EX-5.2 capr-20250910xex5d2.htm EX-5.2 17534
5 EX-23.1 capr-20250910xex23d1.htm EX-23.1 4177
6 EX-FILING FEES capr-20250910xexfees.htm   iXBRL EX-FILING FEES 50986
7 GRAPHIC capr-20250910xex5d1002.jpg GRAPHIC 4308
8 GRAPHIC capr-20250910xex5d2002.jpg GRAPHIC 4308
9 GRAPHIC capr-20250910xs3001.jpg GRAPHIC 11611
10 GRAPHIC capr-20250910xs3002.jpg GRAPHIC 9429
  Complete submission text file 0001104659-25-089126.txt   1271017

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT capr-20250910xexfees_htm.xml XML 17320
Mailing Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121
Business Address 10865 ROAD TO THE CURE SUITE 150 SAN DIEGO CA 92121 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-290179 | Film No.: 251306666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)